Literature DB >> 17928166

The incremental inpatient costs associated with marijuana comorbidity.

Rosalie Liccardo Pacula1, Jeanne Ringel, Carlos Dobkin, Khoa Truong.   

Abstract

In this paper we examine the incremental cost of marijuana comorbidity for alcohol, mood and thought diagnoses in hospital settings. We use data from the 1993-2000 National Hospital Discharge Survey to examine the effect on length of stay and the 1995-2000 Florida Hospital Discharge Data to examine charges. General linear modeling (GLM) and propensity score methods are employed to deal with concerns stemming from the distribution of the dependent variables and statistically significant differences in the baseline characteristics of marijuana users versus non-users. Marijuana comorbidity is associated with longer length of stays and higher charges for patients suffering from a primary diagnosis of an alcohol problem. We also find higher average charges for patients suffering from mood disorders, though the finding is not robust across all model specifications. We do not find any significant effects for thought disorders. Findings from this study suggest that a marijuana comorbidity increases the cost of treating patients with alcohol problems and mood disorder diagnoses, implying that there may be real health consequences associated with marijuana abuse and dependence and more work considering this possibility is warranted.

Entities:  

Mesh:

Year:  2007        PMID: 17928166      PMCID: PMC2212669          DOI: 10.1016/j.drugalcdep.2007.08.011

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  9 in total

1.  The economic costs of heroin addiction in the United States.

Authors:  T L Mark; G E Woody; T Juday; H D Kleber
Journal:  Drug Alcohol Depend       Date:  2001-01-01       Impact factor: 4.492

2.  Cannabis use and public health: assessing the burden.

Authors:  W Hall; T F Babor
Journal:  Addiction       Date:  2000-04       Impact factor: 6.526

3.  Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study.

Authors:  A Jablensky; N Sartorius; G Ernberg; M Anker; A Korten; J E Cooper; R Day; A Bertelsen
Journal:  Psychol Med Monogr Suppl       Date:  1992

4.  Early onset cannabis use and psychosocial adjustment in young adults.

Authors:  D M Fergusson; L J Horwood
Journal:  Addiction       Date:  1997-03       Impact factor: 6.526

5.  The cost of medical care for patients with diabetes, hypertension and both conditions: does alcohol use play a role?

Authors:  M T French; M P Mundt; M Fleming; S K Zavala
Journal:  J Intern Med       Date:  2005-07       Impact factor: 8.989

6.  Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function.

Authors:  J M Cleghorn; R D Kaplan; B Szechtman; H Szechtman; G M Brown; S Franco
Journal:  J Clin Psychiatry       Date:  1991-01       Impact factor: 4.384

7.  Cannabis abuse and the course of recent-onset schizophrenic disorders.

Authors:  D H Linszen; P M Dingemans; M E Lenior
Journal:  Arch Gen Psychiatry       Date:  1994-04

8.  Health care use by frequent marijuana smokers who do not smoke tobacco.

Authors:  M R Polen; S Sidney; I S Tekawa; M Sadler; G D Friedman
Journal:  West J Med       Date:  1993-06

9.  Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002.

Authors:  Wilson M Compton; Bridget F Grant; James D Colliver; Meyer D Glantz; Frederick S Stinson
Journal:  JAMA       Date:  2004-05-05       Impact factor: 56.272

  9 in total
  5 in total

1.  Developing public health regulations for marijuana: lessons from alcohol and tobacco.

Authors:  Rosalie Liccardo Pacula; Beau Kilmer; Alexander C Wagenaar; Frank J Chaloupka; Jonathan P Caulkins
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

2.  The Effects of Marijuana Use on Transitions through Stages of Alcohol Involvement for Men and Women in the NESARC I and II.

Authors:  Kerry M Green; Beth A Reboussin; Lauren R Pacek; Carla L Storr; Ramin Mojtabai; Bernadette A Cullen; Rosa M Crum
Journal:  Subst Use Misuse       Date:  2019-07-12       Impact factor: 2.164

3.  Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever.

Authors:  Yuyan Shi
Journal:  Drug Alcohol Depend       Date:  2017-02-21       Impact factor: 4.492

4.  Cannabis use during alcohol treatment is associated with alcohol-related problems one-year post-treatment.

Authors:  Meenakshi S Subbaraman; Jane Metrik; Deidre Patterson; Robert L Stout
Journal:  Drug Alcohol Depend       Date:  2018-10-04       Impact factor: 4.492

5.  Analysis of Hospitalization Length of Stay and Total Charges for Patients with Drug Abuse Comorbidity.

Authors:  Memory Ndanga; Shankar Srinivasan
Journal:  Cureus       Date:  2019-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.